Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 01, 2026
Intrahepatic cholangiocarcinoma: the equity gap in one of the most lethal cancers.
Journal: Journal of gastrointestinal oncology
Published: February 24, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026
Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.
Journal: Cancer
Published: December 21, 2025
Sexual Health in Cancer Care-A Gap in Understanding.
Journal: JAMA internal medicine
Published: November 24, 2025
A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling.
Journal: Cancer letters
Published: July 29, 2025
Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101.
Journal: Future oncology (London, England)
Published: March 31, 2025
A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations.
Journal: The oncologist
Published: December 09, 2024
Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177 Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell Anemia.
Journal: Clinical nuclear medicine
Published: December 04, 2024
Last Updated: 09/26/2026